Arylsulphonamide hydroxamic acids as potent inhibitors of MMP-13

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.9, 1999-09, pp. : 1303-1307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cyclic N-hydroxamic acid inhibitors of TNF- synthesis and MMP-13

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1951-1956

Informa Healthcare

Access to resources Recommend Favorite

Sulfonate Ester Hydroxamic Acids as Potent and Selective Inhibitors of TACE Enzyme

By LEVIN JEREMY DU MILA

Drug Design and Discovery, Vol. 18, Iss. 4, 2003-01 ,pp. : 123-126

Taylor & Francis Ltd

Access to resources Recommend Favorite

New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents

Medicinal Chemistry, Vol. 9, Iss. 8, 2013-01 ,pp. : 1051-1057

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxamic Acids Designed as Inhibitors of Urease

Letters in Drug Design & Discovery, Vol. 6, Iss. 3, 2009-04 ,pp. : 186-192

Bentham Science Publishers

Access to resources Recommend Favorite

MMP-13 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 237-241

Informa Healthcare

Access to resources Recommend Favorite